|
1
|
Nathan DM, Cleary PA, Backlund JY, Genuth
SM, Lachin JM, Orchard TJ, Raskin P and Zinman B: DiabetesControl
and Complications Trial/Epidemiology of Diabetes Interventions and
Complications (DCCT/EDIC) Study Research Group: Intensive diabetes
treatment and cardiovascular disease in patients with type 1
diabetes. N Engl J Med. 353:2643–2653. 2005.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Severino P, D'Amato A, Netti L, Pucci M,
De Marchis M, Palmirotta R, Volterrani M, Mancone M and Fedele F:
Diabetes mellitus and ischemic heart disease: The role of ion
channels. Int J Mol Sci. 19(E802)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bytzer P, Talley NJ, Leemon M, Young LJ,
Jones MP and Horowitz M: Prevalence of gastrointestinal symptoms
associated with diabetes mellitus: A population-based survey of
15,000 adults. Arch Intern Med. 161:1989–1996. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Samsom M, Vermeijden JR, Smout AJ, Van
Doorn E, Roelofs J, Van Dam PS, Martens EP, Eelkman-Rooda SJ and
Van Berge-Henegouwen GP: Prevalence of delayed gastric emptying in
diabetic patients and relationship to dyspeptic symptoms: A
prospective study in unselected diabetic patients. Diabetes Care.
26:3116–3122. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rodrigues ML and Motta ME: Mechanisms and
factors associated with gastrointestinal symptoms in patients with
diabetes mellitus. J Pediatr (Rio J). 88:17–24. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sanders KM, Koh SD, Ro S and Ward SM:
Regulation of gastrointestinal motility-insights from smooth muscle
biology. Nat Rev Gastroenterol Hepatol. 9:633–645. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sun M, Wang F and Feng P: Insulin-like
growth factor-1 inhibits colonic smooth muscle cell apoptosis in
diabetic rats with colonic dysmotility. Regul Pept. 194-195:41–48.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2(e363)2004.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Miao S, Mao X, Pei R, Song K, Lv Y, Jiang
H, Li B, Yang X, Xiu C, Meng H and Sun J: MiR-448 inhibits
laryngeal cancer metastasis by repressing AEG-1 expression. Int J
Clin Exp Med. 11:1587–1596. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cao M, Bai L, Wang D, Zhai Q, Li Y, Hai J
and Wang W: miRNA-33 expression and its mechanism in patients and
model rats with type 2 diabetic nephropathy. Int J Clin Exp Med.
11:1661–1668. 2018.
|
|
17
|
Gao Y, Liu Z, Ding Z, Hou S, Li J and
Jiang K: MicroRNA-155 increases colon cancer chemoresistance to
cisplatin by targeting forkhead box O3. Oncol Lett. 15:4781–4788.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu J, Chen Z, Xiang J and Gu X:
MicroRNA-155 acts as a tumor suppressor in colorectal cancer by
targeting CTHRC1 in vitro. Oncol Lett. 15:5561–5568.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Gao J, Zhao G, Li W, Zhang J, Che Y, Song
M, Gao S, Zeng B and Wang Y: MiR-155 targets PTCH1 to mediate
endothelial progenitor cell dysfunction caused by high glucose. Exp
Cell Res. 366:55–62. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Pathak S, Grillo AR, Scarpa M, Brun P,
D'Incà R, Nai L, Banerjee A, Cavallo D, Barzon L, Palù G, et al:
MiR-155 modulates the inflammatory phenotype of intestinal
myofibroblasts by targeting SOCS1 in ulcerative colitis. Exp Mol
Med. 47(e164)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dweep H and Gretz N: miRWalk2.0: a
comprehensive atlas of microRNA-target interactions. Nat Methods.
12(697)2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dahan D, Ekman M, Larsson-Callerfelt AK,
Turczyńska K, Boettger T, Braun T, Swärd K and Albinsson S:
Induction of angiotensin-converting enzyme after miR-143/145
deletion is critical for impaired smooth muscle contractility. Am J
Physiol Cell Physiol. 307:C1093–C1101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nijhuis A, Biancheri P, Lewis A, Bishop
CL, Giuffrida P, Chan C, Feakins R, Poulsom R, Di Sabatino A,
Corazza GR, et al: In Crohn's disease fibrosis-reduced expression
of the miR-29 family enhances collagen expression in intestinal
fibroblasts. Clin Sci (Lond). 127:341–350. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Park M, Choi S, Kim S, Kim J, Lee DK, Park
W, Kim T, Jung J, Hwang JY, Won MH, et al: NF-kB-responsive miR-155
induces functional impairment of vascular smooth muscle cells by
downregulating soluble guanylyl cyclase. Exp Mol Med.
51(17)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao XS, Han B, Zhao JX, Tao N and Dong
CY: MiR-155-5p affects Wilms' tumor cell proliferation and
apoptosis via targeting CREB1. Eur Rev Med Pharmacol Sci.
23:1030–1037. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang C, Zhang C, Liu L, A X, Chen B, Li Y
and Du J: Macrophage-derived mir-155-containing exosomes suppress
fibroblast proliferation and promote fibroblast inflammation during
cardiac injury. Mol Ther. 25:192–204. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ji H, Tian D, Zhang B, Zhang Y, Yan D and
Wu S: Overexpression of miR-155 in clear-cell renal cell carcinoma
and its oncogenic effect through targeting FOXO3a. Exp Ther Med.
13:2286–2292. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li DP, Fan J, Wu YJ, Xie YF, Zha JM and
Zhou XM: MiR-155 up-regulated by TGF-β promotes
epithelial-mesenchymal transition, invasion and metastasis of human
hepatocellular carcinoma cells in vitro. Am J Transl Res.
9:2956–2965. 2017.PubMed/NCBI
|
|
29
|
Liu F, Song D, Wu Y, Liu X, Zhu J and Tang
Y: MiR-155 inhibits proliferation and invasion by directly
targeting PDCD4 in non-small cell lung cancer. Thorac Cancer.
8:613–619. 2017.PubMed/NCBI View Article : Google Scholar
|
